AccessibilityHelpAbout Us

Electra Therapeutics(NASDAQ) ETRA

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-7%
5 YearN/A
1 YearN/A
1 MonthN/A
$14.00
+5.62%
+0.75Today
After hours$13.82-$0.18 (-1.29%)
Electra Therapeutics last closing stock price
MetricPriceDate
Last closeUSD 13.922026-09-21
Electra Therapeutics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
Since inception-7.2%USD 15.002026-09-16

Electra Therapeutics Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$14.00

Volume

813,177.48

Open

$13.94

Previous Close

$13.92

Daily Range

$13.48 - $14.48

52-Week Range

$13.25 - $15.50

Estimated Earnings Date

N/A

ETRA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Electra Therapeutics

Electra Therapeutics Inc. is a clinical stage biotechnology company focused on developing innovative therapies targeting diseases in immunology and cancer. Founded in 2018 and headquartered in South San Francisco, the company aims to address unmet medical needs through its cutting-edge research and development efforts.

Products and Services
  • Therapies targeting novel immunology and cancer pathways
  • Clinical trials aimed at evaluating safety and efficacy
  • Collaborations with research institutions for advanced studies
Growth Outlook
  • Strong pipeline with multiple candidates in clinical trials
  • Potential market expansion as immunotherapy gains traction
  • Increased interest in biotechnology investments driving innovation
Financial Highlights
  • Market capitalization of approximately $286 million
  • Stock price range between $13.31 and $15.5 over the past year
  • Recent trading volume of over 4.8 million shares
Electra Therapeutics Inc. is positioned in the healthcare sector, specifically within the medical pharmaceuticals industry. The company is actively engaged in developing therapies that target novel pathways, which could lead to significant advancements in treatment options for patients suffering from immunological and oncological conditions. The strong growth outlook is supported by a robust pipeline and increasing market interest in biotechnology, which may enhance the company's potential for future success. Recent financial highlights indicate a solid market presence, with a notable trading volume and a competitive stock price range, reflecting investor interest in the company's innovative approach to healthcare challenges.
AI Generated • Sep 18, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

South San Francisco, CA, US

ETRA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

813.18K

Avg. Volume

1.98M

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Electra Therapeutics Performance Analysis

Electra Therapeutics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20252025-12-31USD 0N/A
Electra Therapeutics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20252025-12-31USD -0.99N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,763.63+0.01%
^DJIDJI
$52,032.71+0.01%
^IXICNASDAQ
$27,092.05+0.02%
BTCBitcoin
$85,915.00+0.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
WBDWarner Bros. Discovery
$30.80+10.79%
GRMLGreenland Mines
$9.42+230.53%
INTCIntel
$121.78+12.14%
NVDANvidia
$227.38+2.30%

Questions About ETRA

What is the current price of Electra Therapeutics?

Electra Therapeutics is trading at $13.92 per share.

What is the 52-week range for Electra Therapeutics?

Over the past 52 weeks, Electra Therapeutics has traded between $13.25 and $15.50.

How much debt does Electra Therapeutics have?

As of the most recent reporting period, Electra Therapeutics reported total debt of $2.09M.

How much cash does Electra Therapeutics have on hand?

Electra Therapeutics reported $33.01M in cash and cash equivalents in its most recent financial results.

What is Electra Therapeutics’s dividend yield?

Electra Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services